<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:f5b806d5-b9e8-4cc6-be07-d9ae8ab18140,g:6509a911-a1ca-42d2-a45e-ad85f25c3ee5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="rnac-20231231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7ea84c89-4ee0-44a9-9dd0-f2f43b47754f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d5b4f8f5-4a32-455f-beb2-20d139978a56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7ea84c89-4ee0-44a9-9dd0-f2f43b47754f" xlink:to="loc_us-gaap_CommonStockValue_d5b4f8f5-4a32-455f-beb2-20d139978a56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_374156cb-507c-475c-be8e-37fb0d76395d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7ea84c89-4ee0-44a9-9dd0-f2f43b47754f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_374156cb-507c-475c-be8e-37fb0d76395d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7be6f63e-bf90-4ab8-a70f-059b533f880b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7ea84c89-4ee0-44a9-9dd0-f2f43b47754f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7be6f63e-bf90-4ab8-a70f-059b533f880b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_069c6eb4-203b-4061-9a16-ce53dc21b231" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7ea84c89-4ee0-44a9-9dd0-f2f43b47754f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_069c6eb4-203b-4061-9a16-ce53dc21b231" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_36301eac-2816-47dd-8775-fa5c298ba2df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7ea84c89-4ee0-44a9-9dd0-f2f43b47754f" xlink:to="loc_us-gaap_PreferredStockValue_36301eac-2816-47dd-8775-fa5c298ba2df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_69ff5791-2c82-4df3-8a09-20fd21ca7c57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_abd62f07-e6f0-4f45-a2fb-b6c35910a61d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_69ff5791-2c82-4df3-8a09-20fd21ca7c57" xlink:to="loc_us-gaap_AssetsCurrent_abd62f07-e6f0-4f45-a2fb-b6c35910a61d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8c4c4984-15ec-48ba-b7e9-84fb84325e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_69ff5791-2c82-4df3-8a09-20fd21ca7c57" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8c4c4984-15ec-48ba-b7e9-84fb84325e2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_a9645476-db4a-465b-9a7d-1e92a35765c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_69ff5791-2c82-4df3-8a09-20fd21ca7c57" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_a9645476-db4a-465b-9a7d-1e92a35765c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_38399328-4c42-4d3e-b80f-fd0b7fdcf3e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_69ff5791-2c82-4df3-8a09-20fd21ca7c57" xlink:to="loc_us-gaap_Goodwill_38399328-4c42-4d3e-b80f-fd0b7fdcf3e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_16083dae-79ec-4ac1-a396-0694ddcfa411" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_69ff5791-2c82-4df3-8a09-20fd21ca7c57" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_16083dae-79ec-4ac1-a396-0694ddcfa411" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_48d72695-425f-4c20-b208-ed8119cede25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_69ff5791-2c82-4df3-8a09-20fd21ca7c57" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_48d72695-425f-4c20-b208-ed8119cede25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_85cdfae8-be85-4387-8ef8-a3fb77ddccd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_69ff5791-2c82-4df3-8a09-20fd21ca7c57" xlink:to="loc_us-gaap_OtherAssets_85cdfae8-be85-4387-8ef8-a3fb77ddccd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f398a95a-b0aa-4ccf-8a37-3d923636a18d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_69ff5791-2c82-4df3-8a09-20fd21ca7c57" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f398a95a-b0aa-4ccf-8a37-3d923636a18d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d907c9fb-6049-4c95-8848-012ea8621472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_1048166b-6bbe-4200-8e99-43616c299d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d907c9fb-6049-4c95-8848-012ea8621472" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_1048166b-6bbe-4200-8e99-43616c299d8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_89502e1c-b2b4-4310-af77-150ee822c8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d907c9fb-6049-4c95-8848-012ea8621472" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_89502e1c-b2b4-4310-af77-150ee822c8ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_830a29bb-c290-4263-bf32-35bd006b870e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d907c9fb-6049-4c95-8848-012ea8621472" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_830a29bb-c290-4263-bf32-35bd006b870e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_85050cd5-9fcf-4da4-bcd9-9ba6ca5acf03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d907c9fb-6049-4c95-8848-012ea8621472" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_85050cd5-9fcf-4da4-bcd9-9ba6ca5acf03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2fa6523f-4ead-449c-98af-436128fd6afa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d907c9fb-6049-4c95-8848-012ea8621472" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2fa6523f-4ead-449c-98af-436128fd6afa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_182d2467-e9ff-44b7-ac2a-e7238bbb15e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_824ad543-daa7-4bec-b940-bc40df519404" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_182d2467-e9ff-44b7-ac2a-e7238bbb15e4" xlink:to="loc_us-gaap_Liabilities_824ad543-daa7-4bec-b940-bc40df519404" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_441a6a6d-c196-4f82-b2d4-0f9f7733c845" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_182d2467-e9ff-44b7-ac2a-e7238bbb15e4" xlink:to="loc_us-gaap_StockholdersEquity_441a6a6d-c196-4f82-b2d4-0f9f7733c845" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1d34e332-f0b1-4862-93c4-2b2e01807734" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_182d2467-e9ff-44b7-ac2a-e7238bbb15e4" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1d34e332-f0b1-4862-93c4-2b2e01807734" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_TemporaryEquityOptionsCarryingAmountAttributableToParent_ecf04de1-78ab-466a-8a6c-73e90982bca8" xlink:href="rnac-20231231.xsd#rnac_TemporaryEquityOptionsCarryingAmountAttributableToParent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_182d2467-e9ff-44b7-ac2a-e7238bbb15e4" xlink:to="loc_rnac_TemporaryEquityOptionsCarryingAmountAttributableToParent_ecf04de1-78ab-466a-8a6c-73e90982bca8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_5e9fe27d-73a9-4478-b9c1-606900688b46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_182d2467-e9ff-44b7-ac2a-e7238bbb15e4" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_5e9fe27d-73a9-4478-b9c1-606900688b46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e4ea0a89-c4c8-4d75-8390-820444c9c562" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b58bbd86-b168-48a9-8e33-1c1c23c809f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e4ea0a89-c4c8-4d75-8390-820444c9c562" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b58bbd86-b168-48a9-8e33-1c1c23c809f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_de6d4faa-1d6a-4c1d-8caf-9f25b3a71ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e4ea0a89-c4c8-4d75-8390-820444c9c562" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_de6d4faa-1d6a-4c1d-8caf-9f25b3a71ef9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cee85996-6384-4f17-b5d0-662b11a34b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e4ea0a89-c4c8-4d75-8390-820444c9c562" xlink:to="loc_us-gaap_LiabilitiesCurrent_cee85996-6384-4f17-b5d0-662b11a34b7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansPayable_d3b01080-ae7d-4880-b1b2-88bad9b6f177" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermLoansPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e4ea0a89-c4c8-4d75-8390-820444c9c562" xlink:to="loc_us-gaap_LongTermLoansPayable_d3b01080-ae7d-4880-b1b2-88bad9b6f177" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiabilityNoncurrent_2f08a9da-94d0-46e0-bf33-4c42f214697d" xlink:href="rnac-20231231.xsd#rnac_ContingentValueRightLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e4ea0a89-c4c8-4d75-8390-820444c9c562" xlink:to="loc_rnac_ContingentValueRightLiabilityNoncurrent_2f08a9da-94d0-46e0-bf33-4c42f214697d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_649ea833-c3d6-49ff-a2b2-85779073bf93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e4ea0a89-c4c8-4d75-8390-820444c9c562" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_649ea833-c3d6-49ff-a2b2-85779073bf93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_WarrantsAndRightsOutstandingNoncurrent_ec7e29d2-ea83-49c3-8769-fd3add72e3ab" xlink:href="rnac-20231231.xsd#rnac_WarrantsAndRightsOutstandingNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e4ea0a89-c4c8-4d75-8390-820444c9c562" xlink:to="loc_rnac_WarrantsAndRightsOutstandingNoncurrent_ec7e29d2-ea83-49c3-8769-fd3add72e3ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_07c49e10-c7b7-4580-b45e-14b8aca90d37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_483580f7-c7cb-42d9-b6fc-ae9cb8743d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_07c49e10-c7b7-4580-b45e-14b8aca90d37" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_483580f7-c7cb-42d9-b6fc-ae9cb8743d2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_46602175-1727-4973-9f0b-37f2ce18e50a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_07c49e10-c7b7-4580-b45e-14b8aca90d37" xlink:to="loc_us-gaap_AccountsPayableCurrent_46602175-1727-4973-9f0b-37f2ce18e50a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_71fa621c-c028-4401-94b5-0556f775adc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_07c49e10-c7b7-4580-b45e-14b8aca90d37" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_71fa621c-c028-4401-94b5-0556f775adc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableCurrent_a3f2a225-65c0-4d6e-8371-1a9187e2e535" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_07c49e10-c7b7-4580-b45e-14b8aca90d37" xlink:to="loc_us-gaap_LoansPayableCurrent_a3f2a225-65c0-4d6e-8371-1a9187e2e535" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_WarrantsAndRightsOutstandingCurrent_a7e7b195-b141-472a-810c-710ed2e7c96b" xlink:href="rnac-20231231.xsd#rnac_WarrantsAndRightsOutstandingCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_07c49e10-c7b7-4580-b45e-14b8aca90d37" xlink:to="loc_rnac_WarrantsAndRightsOutstandingCurrent_a7e7b195-b141-472a-810c-710ed2e7c96b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_031d4a88-4ead-45d8-8291-d002fe6d58cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_07c49e10-c7b7-4580-b45e-14b8aca90d37" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_031d4a88-4ead-45d8-8291-d002fe6d58cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiabilityCurrent_ed937a2b-d820-436f-8488-b79a48339cf3" xlink:href="rnac-20231231.xsd#rnac_ContingentValueRightLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_07c49e10-c7b7-4580-b45e-14b8aca90d37" xlink:to="loc_rnac_ContingentValueRightLiabilityCurrent_ed937a2b-d820-436f-8488-b79a48339cf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_68f0e375-951f-439d-9516-b37df2f7453c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_07c49e10-c7b7-4580-b45e-14b8aca90d37" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_68f0e375-951f-439d-9516-b37df2f7453c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss" xlink:type="simple" xlink:href="rnac-20231231.xsd#ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3f37cb89-2bc6-4bcf-9330-1e16b3fff27c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2b4e4a78-cff3-40fc-8996-42dc315368eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3f37cb89-2bc6-4bcf-9330-1e16b3fff27c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_2b4e4a78-cff3-40fc-8996-42dc315368eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_8a35504f-6349-48aa-aa3f-a1b33107c5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3f37cb89-2bc6-4bcf-9330-1e16b3fff27c" xlink:to="loc_us-gaap_InvestmentIncomeNet_8a35504f-6349-48aa-aa3f-a1b33107c5aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_cf3ff7c4-e116-4751-a30f-bb721734d4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3f37cb89-2bc6-4bcf-9330-1e16b3fff27c" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_cf3ff7c4-e116-4751-a30f-bb721734d4ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2834c905-6c34-4c5c-b6a0-312ecd40796d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3f37cb89-2bc6-4bcf-9330-1e16b3fff27c" xlink:to="loc_us-gaap_OperatingIncomeLoss_2834c905-6c34-4c5c-b6a0-312ecd40796d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_049485bd-8bc8-497b-a461-b4989e37563b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3f37cb89-2bc6-4bcf-9330-1e16b3fff27c" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_049485bd-8bc8-497b-a461-b4989e37563b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_070fb34a-66e9-48ad-b014-00a61c5aeff8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3f37cb89-2bc6-4bcf-9330-1e16b3fff27c" xlink:to="loc_us-gaap_InterestExpense_070fb34a-66e9-48ad-b014-00a61c5aeff8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_d9361ae6-b759-4709-8d51-6c32f062cbaa" xlink:href="rnac-20231231.xsd#rnac_FairValueAdjustmentOfContingentValueRightLiability"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3f37cb89-2bc6-4bcf-9330-1e16b3fff27c" xlink:to="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_d9361ae6-b759-4709-8d51-6c32f062cbaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_fb752450-48dc-4960-a9f2-1f4e603b470e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3f37cb89-2bc6-4bcf-9330-1e16b3fff27c" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_fb752450-48dc-4960-a9f2-1f4e603b470e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a724aa3c-3ce9-484d-961e-c3cda7a7f757" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ac0c85ce-f70c-46fe-b123-df207106ee28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a724aa3c-3ce9-484d-961e-c3cda7a7f757" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ac0c85ce-f70c-46fe-b123-df207106ee28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44f7ced4-51a4-4772-8318-483139ddd8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a724aa3c-3ce9-484d-961e-c3cda7a7f757" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44f7ced4-51a4-4772-8318-483139ddd8a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b9613218-6f79-44dc-8ef2-00f5035b96c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_69a95513-34d0-4226-bf90-d960c964f300" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_b9613218-6f79-44dc-8ef2-00f5035b96c4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_69a95513-34d0-4226-bf90-d960c964f300" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ce602370-3f4b-41b9-8394-91c191737df6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_b9613218-6f79-44dc-8ef2-00f5035b96c4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ce602370-3f4b-41b9-8394-91c191737df6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1a53b37e-76dd-46e4-8cd8-8da18b89f91a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b1454f52-5d9a-4b83-850a-d48689115ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1a53b37e-76dd-46e4-8cd8-8da18b89f91a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b1454f52-5d9a-4b83-850a-d48689115ca7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c9e05a42-b722-4170-98c9-93dfdcaad42a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1a53b37e-76dd-46e4-8cd8-8da18b89f91a" xlink:to="loc_us-gaap_OperatingExpenses_c9e05a42-b722-4170-98c9-93dfdcaad42a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c03bf75e-cbe6-4ad8-af92-2f69da0f838f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4de5d755-16ad-4c01-853e-767bb6d550b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c03bf75e-cbe6-4ad8-af92-2f69da0f838f" xlink:to="loc_us-gaap_NetIncomeLoss_4de5d755-16ad-4c01-853e-767bb6d550b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0e087383-0803-4ab3-a9d5-84314ec8fe75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c03bf75e-cbe6-4ad8-af92-2f69da0f838f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0e087383-0803-4ab3-a9d5-84314ec8fe75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_73db920e-9af2-4a75-b21f-fee821d41b52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c03bf75e-cbe6-4ad8-af92-2f69da0f838f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_73db920e-9af2-4a75-b21f-fee821d41b52" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="rnac-20231231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_38a361b2-0105-4082-bbb3-0e4ca34e0d83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a52f62d-95dd-4c9e-871f-928526b7075e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_38a361b2-0105-4082-bbb3-0e4ca34e0d83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a52f62d-95dd-4c9e-871f-928526b7075e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d70b7db0-038d-427f-b1b4-a0f0d77b29fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_38a361b2-0105-4082-bbb3-0e4ca34e0d83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d70b7db0-038d-427f-b1b4-a0f0d77b29fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0072b32c-75e3-4eea-be31-8f9fdd0a2288" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_38a361b2-0105-4082-bbb3-0e4ca34e0d83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0072b32c-75e3-4eea-be31-8f9fdd0a2288" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b417612b-37a7-4e50-ac3c-079a9954f446" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_38a361b2-0105-4082-bbb3-0e4ca34e0d83" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b417612b-37a7-4e50-ac3c-079a9954f446" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_7a18fa58-6c41-4940-8a59-7642000e6e92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_7a18fa58-6c41-4940-8a59-7642000e6e92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a82bf29e-ddd1-41c8-8ace-fdbe9b0c5a10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a82bf29e-ddd1-41c8-8ace-fdbe9b0c5a10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_32c70e1a-efdd-41fe-bb09-501ad647d6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaidInKindInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_PaidInKindInterest_32c70e1a-efdd-41fe-bb09-501ad647d6b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_f0f21166-4037-4d21-8c96-b5f257e1e823" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_f0f21166-4037-4d21-8c96-b5f257e1e823" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_e142eec7-f9f7-476a-8164-729caa216acd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_e142eec7-f9f7-476a-8164-729caa216acd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_fe98b9a8-eb07-4438-8309-0d58083eea2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_fe98b9a8-eb07-4438-8309-0d58083eea2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_20fd8aa1-8562-4962-aeeb-731c5a47ce17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_ShareBasedCompensation_20fd8aa1-8562-4962-aeeb-731c5a47ce17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_IncreaseDecreaseInContractWithCustomerAssetAllowanceForCreditLossCurrent_defcb76a-6ef1-4205-b6e2-6ecf209699cc" xlink:href="rnac-20231231.xsd#rnac_IncreaseDecreaseInContractWithCustomerAssetAllowanceForCreditLossCurrent"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_rnac_IncreaseDecreaseInContractWithCustomerAssetAllowanceForCreditLossCurrent_defcb76a-6ef1-4205-b6e2-6ecf209699cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_5669be47-caeb-41be-8473-bddaa4255765" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_5669be47-caeb-41be-8473-bddaa4255765" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_bbd23c9c-8390-47e1-ba2b-c36b331e3b30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_bbd23c9c-8390-47e1-ba2b-c36b331e3b30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_856f8cf0-8d0d-456d-8e19-6bbd7eb65d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_856f8cf0-8d0d-456d-8e19-6bbd7eb65d4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_f7c3e5b7-5ab6-48c4-bd5c-c6165ee318f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_f7c3e5b7-5ab6-48c4-bd5c-c6165ee318f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f58123bb-8e47-40a5-aed5-a94a9e170c29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_NetIncomeLoss_f58123bb-8e47-40a5-aed5-a94a9e170c29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_0294b0e9-3610-43da-8447-0c26747912ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_0294b0e9-3610-43da-8447-0c26747912ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_be47655e-b0a7-4749-abc6-067ffcc8269b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_be47655e-b0a7-4749-abc6-067ffcc8269b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a3efe1b2-bb46-45b0-9a67-3e8c88f15ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a3efe1b2-bb46-45b0-9a67-3e8c88f15ed5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_2a15e3b8-e349-4e6e-a5c2-2cabd3385d58" xlink:href="rnac-20231231.xsd#rnac_FairValueAdjustmentOfContingentValueRightLiability"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_2a15e3b8-e349-4e6e-a5c2-2cabd3385d58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bf65b2cf-f10e-4414-a3da-f4441ab472cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bf65b2cf-f10e-4414-a3da-f4441ab472cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_a7cb0943-4e1a-4cf1-b8cd-96e12d6f49f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_a7cb0943-4e1a-4cf1-b8cd-96e12d6f49f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_cf490d3c-b103-441b-b046-4e95b82b6a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_833692bd-4f05-4177-80c5-ad2327fbecad" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_cf490d3c-b103-441b-b046-4e95b82b6a6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0c2f7c4-054b-4953-bef1-da53a5586c48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_71607164-bf7f-4de9-9be1-56083de4f48b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0c2f7c4-054b-4953-bef1-da53a5586c48" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_71607164-bf7f-4de9-9be1-56083de4f48b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_92fc287f-6e65-4368-b6f2-55116ad00603" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0c2f7c4-054b-4953-bef1-da53a5586c48" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_92fc287f-6e65-4368-b6f2-55116ad00603" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_3e588a05-bcfe-449c-9a4f-d5f201b35d13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0c2f7c4-054b-4953-bef1-da53a5586c48" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_3e588a05-bcfe-449c-9a4f-d5f201b35d13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ProceedsFromIssuanceOfCommonStockAndWarrants_4daaf96f-ef0d-4b1d-ba5f-a0a7636a16f4" xlink:href="rnac-20231231.xsd#rnac_ProceedsFromIssuanceOfCommonStockAndWarrants"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0c2f7c4-054b-4953-bef1-da53a5586c48" xlink:to="loc_rnac_ProceedsFromIssuanceOfCommonStockAndWarrants_4daaf96f-ef0d-4b1d-ba5f-a0a7636a16f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_fd775f31-c41f-400c-b781-2d18e4c4c8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0c2f7c4-054b-4953-bef1-da53a5586c48" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_fd775f31-c41f-400c-b781-2d18e4c4c8f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_9c86bd9b-9720-4541-bc62-08086b60ca33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0c2f7c4-054b-4953-bef1-da53a5586c48" xlink:to="loc_us-gaap_ProceedsFromStockPlans_9c86bd9b-9720-4541-bc62-08086b60ca33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_09def100-9f98-43d1-aacb-7c64f5e59f16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0c2f7c4-054b-4953-bef1-da53a5586c48" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_09def100-9f98-43d1-aacb-7c64f5e59f16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_PaymentForSettlementOfEquityAwardsInBusinessCombination_aa84ca8d-ce7d-4851-b3c9-661ae86ff223" xlink:href="rnac-20231231.xsd#rnac_PaymentForSettlementOfEquityAwardsInBusinessCombination"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b0c2f7c4-054b-4953-bef1-da53a5586c48" xlink:to="loc_rnac_PaymentForSettlementOfEquityAwardsInBusinessCombination_aa84ca8d-ce7d-4851-b3c9-661ae86ff223" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e44f8fa5-4fc3-4fa2-84ce-65c61a347940" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_4efa9cac-64aa-41e7-9355-94a72b631088" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e44f8fa5-4fc3-4fa2-84ce-65c61a347940" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_4efa9cac-64aa-41e7-9355-94a72b631088" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_fdd66460-60e6-4e2c-bfeb-1d02efb2a3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e44f8fa5-4fc3-4fa2-84ce-65c61a347940" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_fdd66460-60e6-4e2c-bfeb-1d02efb2a3c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_49d543d9-416d-43dc-9aba-1fbdc48b017a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e44f8fa5-4fc3-4fa2-84ce-65c61a347940" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_49d543d9-416d-43dc-9aba-1fbdc48b017a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_80215ce5-d0c8-446e-a636-183ac51b9433" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e44f8fa5-4fc3-4fa2-84ce-65c61a347940" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_80215ce5-d0c8-446e-a636-183ac51b9433" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_ca150c0b-5857-4720-86a1-fd4fc834c477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e44f8fa5-4fc3-4fa2-84ce-65c61a347940" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_ca150c0b-5857-4720-86a1-fd4fc834c477" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/MergerScheduleofFairValueofConsiderationDetails" xlink:type="simple" xlink:href="rnac-20231231.xsd#MergerScheduleofFairValueofConsiderationDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/MergerScheduleofFairValueofConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_95746cf5-8d42-4abe-b73d-6984ff21531f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_3c16da51-5e3a-430e-bfef-af16c6ed24a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_95746cf5-8d42-4abe-b73d-6984ff21531f" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_3c16da51-5e3a-430e-bfef-af16c6ed24a1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/MergerScheduleofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="rnac-20231231.xsd#MergerScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/MergerScheduleofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_26e95b84-549b-4e0e-b732-778901416b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpensesAndOtherCurrentLiabilities_b7893150-020e-47fd-a6dc-8a80e7641907" xlink:href="rnac-20231231.xsd#rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_26e95b84-549b-4e0e-b732-778901416b0a" xlink:to="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpensesAndOtherCurrentLiabilities_b7893150-020e-47fd-a6dc-8a80e7641907" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_57e743bf-0e00-457b-ba83-e9baf43da4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_26e95b84-549b-4e0e-b732-778901416b0a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_57e743bf-0e00-457b-ba83-e9baf43da4cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLeaseLiability_3569552b-e56c-4736-9110-9ce35eb97bde" xlink:href="rnac-20231231.xsd#rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_26e95b84-549b-4e0e-b732-778901416b0a" xlink:to="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLeaseLiability_3569552b-e56c-4736-9110-9ce35eb97bde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiability_c93a0705-85e9-46a4-93ed-4678990da0df" xlink:href="rnac-20231231.xsd#rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_26e95b84-549b-4e0e-b732-778901416b0a" xlink:to="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiability_c93a0705-85e9-46a4-93ed-4678990da0df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f8f22f68-7053-4e67-9fd9-05c9ca89bd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4c945ba0-c621-4a72-bee4-55d2a71c2d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f8f22f68-7053-4e67-9fd9-05c9ca89bd7a" xlink:to="loc_us-gaap_Goodwill_4c945ba0-c621-4a72-bee4-55d2a71c2d3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9f008c39-d6ea-4895-827a-ae37fc4a3b19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f8f22f68-7053-4e67-9fd9-05c9ca89bd7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9f008c39-d6ea-4895-827a-ae37fc4a3b19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_47d9dade-3098-4a7b-9110-477cc4f09216" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f8f22f68-7053-4e67-9fd9-05c9ca89bd7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_47d9dade-3098-4a7b-9110-477cc4f09216" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_6646a4ef-fe8d-442a-b932-6ea741ffe086" xlink:href="rnac-20231231.xsd#rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f8f22f68-7053-4e67-9fd9-05c9ca89bd7a" xlink:to="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_6646a4ef-fe8d-442a-b932-6ea741ffe086" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_741d8080-5ed6-475a-b8aa-e776bdc54090" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f8f22f68-7053-4e67-9fd9-05c9ca89bd7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_741d8080-5ed6-475a-b8aa-e776bdc54090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_a05f692d-d86b-42a0-b543-8d0f2e9bde2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f8f22f68-7053-4e67-9fd9-05c9ca89bd7a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_a05f692d-d86b-42a0-b543-8d0f2e9bde2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d2fc3166-4c29-4516-af20-1a2ab8289e13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2707cc02-da92-40f0-a0f4-f3800fa67701" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d2fc3166-4c29-4516-af20-1a2ab8289e13" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2707cc02-da92-40f0-a0f4-f3800fa67701" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a1faa56b-86ea-499f-8b2e-89a9970a89d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d2fc3166-4c29-4516-af20-1a2ab8289e13" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a1faa56b-86ea-499f-8b2e-89a9970a89d8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/MarketableSecuritiesandInvestmentsSummaryofAvailableforSaleMarketableSecuritiesDetails" xlink:type="simple" xlink:href="rnac-20231231.xsd#MarketableSecuritiesandInvestmentsSummaryofAvailableforSaleMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/MarketableSecuritiesandInvestmentsSummaryofAvailableforSaleMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_584f1777-e077-4a42-96bc-e5a4954b6189" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ad668e86-41e8-440e-9f9f-786f57b1498b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_584f1777-e077-4a42-96bc-e5a4954b6189" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ad668e86-41e8-440e-9f9f-786f57b1498b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b6f5d041-47d7-4852-82af-5ac5273b286e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_584f1777-e077-4a42-96bc-e5a4954b6189" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b6f5d041-47d7-4852-82af-5ac5273b286e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1d6668a5-d3b8-462f-8059-ee97eb4f095d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_584f1777-e077-4a42-96bc-e5a4954b6189" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1d6668a5-d3b8-462f-8059-ee97eb4f095d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/NetLossIncomePerShareComputationofBasicandDilutedNetLossIncomePerShareDetails" xlink:type="simple" xlink:href="rnac-20231231.xsd#NetLossIncomePerShareComputationofBasicandDilutedNetLossIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/NetLossIncomePerShareComputationofBasicandDilutedNetLossIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_fb97d621-c68e-42d7-a117-9d61565beaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c160f60b-1524-4780-9ba3-dedca1f7c7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_fb97d621-c68e-42d7-a117-9d61565beaa7" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c160f60b-1524-4780-9ba3-dedca1f7c7bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities_c56acee4-0c6a-4623-be83-79e6158c3269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DilutiveSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_fb97d621-c68e-42d7-a117-9d61565beaa7" xlink:to="loc_us-gaap_DilutiveSecurities_c56acee4-0c6a-4623-be83-79e6158c3269" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0f12b5c1-6614-49a4-ba90-4c0cd6ec183e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bfa21a11-6435-400c-86de-4ad10ef8d1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0f12b5c1-6614-49a4-ba90-4c0cd6ec183e" xlink:to="loc_us-gaap_NetIncomeLoss_bfa21a11-6435-400c-86de-4ad10ef8d1b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributedEarnings_b0eff333-f65b-4775-a27e-12389ef5491e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DistributedEarnings"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0f12b5c1-6614-49a4-ba90-4c0cd6ec183e" xlink:to="loc_us-gaap_DistributedEarnings_b0eff333-f65b-4775-a27e-12389ef5491e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3c7078b3-f3b9-4596-8ca1-82ad939cd560" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ff14a13c-381a-4639-8cce-52de61e38e08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3c7078b3-f3b9-4596-8ca1-82ad939cd560" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ff14a13c-381a-4639-8cce-52de61e38e08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_fe4ebeaa-ffcf-446d-9421-e67f10f6fc83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3c7078b3-f3b9-4596-8ca1-82ad939cd560" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_fe4ebeaa-ffcf-446d-9421-e67f10f6fc83" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsSummaryofAssetsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="rnac-20231231.xsd#FairValueMeasurementsSummaryofAssetsMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsSummaryofAssetsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_b4a81df7-45a1-42fc-b843-0f6c8107928d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiability_ae6a0acd-2023-47b6-98ce-32574ed14047" xlink:href="rnac-20231231.xsd#rnac_ContingentValueRightLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_b4a81df7-45a1-42fc-b843-0f6c8107928d" xlink:to="loc_rnac_ContingentValueRightLiability_ae6a0acd-2023-47b6-98ce-32574ed14047" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_290120f9-d35c-4113-b759-0db33da689d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_b4a81df7-45a1-42fc-b843-0f6c8107928d" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_290120f9-d35c-4113-b759-0db33da689d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_546dc30a-ed98-4bee-a223-cd707d93e60d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_b4a81df7-45a1-42fc-b843-0f6c8107928d" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_546dc30a-ed98-4bee-a223-cd707d93e60d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_443a4ecf-9a75-41c2-b0e8-2e620da858db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b3cdc7f0-3b6d-4df2-a168-3d124574d636" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_443a4ecf-9a75-41c2-b0e8-2e620da858db" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b3cdc7f0-3b6d-4df2-a168-3d124574d636" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_253f8902-5e39-464a-b5e9-444fe4a87363" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_443a4ecf-9a75-41c2-b0e8-2e620da858db" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_253f8902-5e39-464a-b5e9-444fe4a87363" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="rnac-20231231.xsd#FairValueMeasurementsScheduleofCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a31471a9-9a54-4db2-9b9f-6aeb0eaf86d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_0bf79d9a-23a8-4654-be97-ae161945c5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a31471a9-9a54-4db2-9b9f-6aeb0eaf86d1" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_0bf79d9a-23a8-4654-be97-ae161945c5bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_46845442-8fc6-4966-a09b-5f373832720e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a31471a9-9a54-4db2-9b9f-6aeb0eaf86d1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_46845442-8fc6-4966-a09b-5f373832720e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_54e4e1f8-d955-4f94-a553-b56dd369a8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a31471a9-9a54-4db2-9b9f-6aeb0eaf86d1" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_54e4e1f8-d955-4f94-a553-b56dd369a8b6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="rnac-20231231.xsd#PropertyandEquipmentScheduleofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_429c0763-61b9-40e4-9988-a4d649aa7483" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_60b812c8-1939-42ec-b583-cfb2af79eebe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_429c0763-61b9-40e4-9988-a4d649aa7483" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_60b812c8-1939-42ec-b583-cfb2af79eebe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_32b2749c-eda0-48a8-9589-77a7ecd16f04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_429c0763-61b9-40e4-9988-a4d649aa7483" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_32b2749c-eda0-48a8-9589-77a7ecd16f04" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="rnac-20231231.xsd#AccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_00116f2d-1c80-408e-aeda-a9059f9a16f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_cff651bd-b701-4efc-84d9-7475de3e0f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_00116f2d-1c80-408e-aeda-a9059f9a16f5" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_cff651bd-b701-4efc-84d9-7475de3e0f9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedPatentFeesCurrent_0424cf84-8afa-46c4-bdd7-b58f9a9c586b" xlink:href="rnac-20231231.xsd#rnac_AccruedPatentFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_00116f2d-1c80-408e-aeda-a9059f9a16f5" xlink:to="loc_rnac_AccruedPatentFeesCurrent_0424cf84-8afa-46c4-bdd7-b58f9a9c586b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedResearchAndDevelopmentCostsCurrent_b81f2ce1-ee36-4637-9ab6-01a72b088f04" xlink:href="rnac-20231231.xsd#rnac_AccruedResearchAndDevelopmentCostsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_00116f2d-1c80-408e-aeda-a9059f9a16f5" xlink:to="loc_rnac_AccruedResearchAndDevelopmentCostsCurrent_b81f2ce1-ee36-4637-9ab6-01a72b088f04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedAuditFeesCurrent_3e3832fb-450c-45f5-a765-32935b228cf3" xlink:href="rnac-20231231.xsd#rnac_AccruedAuditFeesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_00116f2d-1c80-408e-aeda-a9059f9a16f5" xlink:to="loc_rnac_AccruedAuditFeesCurrent_3e3832fb-450c-45f5-a765-32935b228cf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedInterestCurrent_417d69ee-119c-4fb1-bbb0-59376b21fd01" xlink:href="rnac-20231231.xsd#rnac_AccruedInterestCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_00116f2d-1c80-408e-aeda-a9059f9a16f5" xlink:to="loc_rnac_AccruedInterestCurrent_417d69ee-119c-4fb1-bbb0-59376b21fd01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d6a52af4-8e4c-4947-9d51-3e5cc3219fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_00116f2d-1c80-408e-aeda-a9059f9a16f5" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d6a52af4-8e4c-4947-9d51-3e5cc3219fa1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="rnac-20231231.xsd#LeasesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_0d2c97bf-4854-4667-9909-a690ef7bc5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_bccef714-df22-40c6-9055-e3d708e21dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestrictedCash_0d2c97bf-4854-4667-9909-a690ef7bc5ce" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_bccef714-df22-40c6-9055-e3d708e21dd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_a0dbafff-8183-4da1-a081-05b375a69848" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestrictedCash_0d2c97bf-4854-4667-9909-a690ef7bc5ce" xlink:to="loc_us-gaap_RestrictedCashCurrent_a0dbafff-8183-4da1-a081-05b375a69848" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesComponentsofLeaseCostsDetails" xlink:type="simple" xlink:href="rnac-20231231.xsd#LeasesComponentsofLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesComponentsofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_dd4d2199-2fc8-4f74-9f61-0bbbc04b935b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_70cdc99f-1ea7-4078-a65b-71276ba1b548" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_dd4d2199-2fc8-4f74-9f61-0bbbc04b935b" xlink:to="loc_us-gaap_VariableLeaseCost_70cdc99f-1ea7-4078-a65b-71276ba1b548" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_82c83264-2a54-4146-b9b7-93c8d0940df1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_dd4d2199-2fc8-4f74-9f61-0bbbc04b935b" xlink:to="loc_us-gaap_SubleaseIncome_82c83264-2a54-4146-b9b7-93c8d0940df1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_3f7d5c12-ca7d-4b83-beee-db099865a7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_dd4d2199-2fc8-4f74-9f61-0bbbc04b935b" xlink:to="loc_us-gaap_OperatingLeaseCost_3f7d5c12-ca7d-4b83-beee-db099865a7c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_60811ffe-d773-4095-ae16-475cf8a6f27f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_dd4d2199-2fc8-4f74-9f61-0bbbc04b935b" xlink:to="loc_us-gaap_ShortTermLeaseCost_60811ffe-d773-4095-ae16-475cf8a6f27f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesOperatingLeaseLiabilityMaturityDetails" xlink:type="simple" xlink:href="rnac-20231231.xsd#LeasesOperatingLeaseLiabilityMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesOperatingLeaseLiabilityMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2a3700fb-a235-4cb1-b0ee-d175b4f5f3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_98b017a1-8517-4b56-aa3a-d8083227b836" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2a3700fb-a235-4cb1-b0ee-d175b4f5f3cb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_98b017a1-8517-4b56-aa3a-d8083227b836" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_de55c8d2-dbc4-4e25-8655-6c717d186de2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2a3700fb-a235-4cb1-b0ee-d175b4f5f3cb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_de55c8d2-dbc4-4e25-8655-6c717d186de2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_81ce9b7d-d3c3-4374-8367-335748e006cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2a3700fb-a235-4cb1-b0ee-d175b4f5f3cb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_81ce9b7d-d3c3-4374-8367-335748e006cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cf15f65d-b695-4d83-89fe-0171f4a66ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2a3700fb-a235-4cb1-b0ee-d175b4f5f3cb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cf15f65d-b695-4d83-89fe-0171f4a66ba6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_020a6d15-dcb6-4eae-a62c-ec4ef19e695f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2a3700fb-a235-4cb1-b0ee-d175b4f5f3cb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_020a6d15-dcb6-4eae-a62c-ec4ef19e695f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_83c3905a-0127-46f6-931e-28249d7705b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2a3700fb-a235-4cb1-b0ee-d175b4f5f3cb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_83c3905a-0127-46f6-931e-28249d7705b1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesOperatingLeaseLiabilityMaturityDetails_1" xlink:type="simple" xlink:href="rnac-20231231.xsd#LeasesOperatingLeaseLiabilityMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesOperatingLeaseLiabilityMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_05248121-2dd7-4940-b926-04be2993873d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7452e24d-ce71-4a49-8b15-ba97019e9b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_05248121-2dd7-4940-b926-04be2993873d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7452e24d-ce71-4a49-8b15-ba97019e9b2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_727b6f78-5483-47ef-8030-b981641be091" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_05248121-2dd7-4940-b926-04be2993873d" xlink:to="loc_us-gaap_OperatingLeaseLiability_727b6f78-5483-47ef-8030-b981641be091" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/RevenueArrangementsScheduleofChangesinContractLiabilitiesDetails" xlink:type="simple" xlink:href="rnac-20231231.xsd#RevenueArrangementsScheduleofChangesinContractLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/RevenueArrangementsScheduleofChangesinContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContractwithCustomerLiabilityIncreaseFromCashReceipts_91002d1f-79b6-4cc1-badf-a7ac33db8b82" xlink:href="rnac-20231231.xsd#rnac_ContractwithCustomerLiabilityIncreaseFromCashReceipts"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContractwithCustomerLiabilityDeferredRevenueIncreaseFromCashReceipts_03e78b16-b234-4598-9881-a9bb83dad071" xlink:href="rnac-20231231.xsd#rnac_ContractwithCustomerLiabilityDeferredRevenueIncreaseFromCashReceipts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rnac_ContractwithCustomerLiabilityIncreaseFromCashReceipts_91002d1f-79b6-4cc1-badf-a7ac33db8b82" xlink:to="loc_rnac_ContractwithCustomerLiabilityDeferredRevenueIncreaseFromCashReceipts_03e78b16-b234-4598-9881-a9bb83dad071" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_bef0444c-54bf-4a4e-84d6-234ed8cc70c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContractwithCustomerLiabilityDeferredRevenue_d20f18e3-acb4-4afa-b5e2-9476298614b8" xlink:href="rnac-20231231.xsd#rnac_ContractwithCustomerLiabilityDeferredRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractWithCustomerLiability_bef0444c-54bf-4a4e-84d6-234ed8cc70c6" xlink:to="loc_rnac_ContractwithCustomerLiabilityDeferredRevenue_d20f18e3-acb4-4afa-b5e2-9476298614b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance_16a13aa6-471a-44cb-a856-1c2834f91887" xlink:href="rnac-20231231.xsd#rnac_ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContractwithCustomerLiabilityDeferredRevenueRevenueRecognized_2b47e13e-41c1-4b8c-8ca1-d21844fd594a" xlink:href="rnac-20231231.xsd#rnac_ContractwithCustomerLiabilityDeferredRevenueRevenueRecognized"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rnac_ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance_16a13aa6-471a-44cb-a856-1c2834f91887" xlink:to="loc_rnac_ContractwithCustomerLiabilityDeferredRevenueRevenueRecognized_2b47e13e-41c1-4b8c-8ca1-d21844fd594a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/IncomeTaxesReconciliationofIncomeTaxesDetails" xlink:type="simple" xlink:href="rnac-20231231.xsd#IncomeTaxesReconciliationofIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/IncomeTaxesReconciliationofIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7dba172d-8274-4066-bcf4-6e7ae5920930" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dbb9f885-a072-411c-af1c-6de363469078" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7dba172d-8274-4066-bcf4-6e7ae5920930" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dbb9f885-a072-411c-af1c-6de363469078" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_b6ecec83-0f62-4cc0-88ea-0071a0b8babf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7dba172d-8274-4066-bcf4-6e7ae5920930" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_b6ecec83-0f62-4cc0-88ea-0071a0b8babf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ea40aad6-3eb0-4c2f-9d56-d64e2968279e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7dba172d-8274-4066-bcf4-6e7ae5920930" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ea40aad6-3eb0-4c2f-9d56-d64e2968279e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_8ea9a8d9-2807-4259-ad57-6029e78f6b93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7dba172d-8274-4066-bcf4-6e7ae5920930" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_8ea9a8d9-2807-4259-ad57-6029e78f6b93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_0917c1ec-d416-4ecb-875d-b40ced814bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7dba172d-8274-4066-bcf4-6e7ae5920930" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_0917c1ec-d416-4ecb-875d-b40ced814bd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_f0adc41a-52b6-4a6b-b4f9-9cc3a2d90a67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7dba172d-8274-4066-bcf4-6e7ae5920930" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_f0adc41a-52b6-4a6b-b4f9-9cc3a2d90a67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_27c94958-85e0-4496-8515-d4f49103c5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7dba172d-8274-4066-bcf4-6e7ae5920930" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_27c94958-85e0-4496-8515-d4f49103c5f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_EffectiveIncomeTaxRateReconciliationDeferredRevenuePercent_8b7f53d6-0338-4727-adc1-ce963a12f1b7" xlink:href="rnac-20231231.xsd#rnac_EffectiveIncomeTaxRateReconciliationDeferredRevenuePercent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7dba172d-8274-4066-bcf4-6e7ae5920930" xlink:to="loc_rnac_EffectiveIncomeTaxRateReconciliationDeferredRevenuePercent_8b7f53d6-0338-4727-adc1-ce963a12f1b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfContractLiabilitiesPercent_86da8116-f690-4902-a8df-2443a83ea06d" xlink:href="rnac-20231231.xsd#rnac_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfContractLiabilitiesPercent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7dba172d-8274-4066-bcf4-6e7ae5920930" xlink:to="loc_rnac_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfContractLiabilitiesPercent_86da8116-f690-4902-a8df-2443a83ea06d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/IncomeTaxesDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" xlink:type="simple" xlink:href="rnac-20231231.xsd#IncomeTaxesDeferredTaxAssetsandDeferredTaxLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/IncomeTaxesDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_2eefa732-29b0-4f34-9e7f-18854473e7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_426ae19d-d23e-437d-8c06-c57e888cc443" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_2eefa732-29b0-4f34-9e7f-18854473e7b1" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_426ae19d-d23e-437d-8c06-c57e888cc443" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_b35449db-8b3b-4653-8646-3b9121cc7ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_2eefa732-29b0-4f34-9e7f-18854473e7b1" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_b35449db-8b3b-4653-8646-3b9121cc7ac8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_044d166d-18a1-4ce3-b303-9461457ea492" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_2eefa732-29b0-4f34-9e7f-18854473e7b1" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_044d166d-18a1-4ce3-b303-9461457ea492" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_d18201b3-9221-4324-94b5-fb35cd30e309" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_DeferredTaxAssetsNetOfDeferredTaxLiabilities_18cb2da3-1420-4260-9314-bbe73e7c96aa" xlink:href="rnac-20231231.xsd#rnac_DeferredTaxAssetsNetOfDeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_d18201b3-9221-4324-94b5-fb35cd30e309" xlink:to="loc_rnac_DeferredTaxAssetsNetOfDeferredTaxLiabilities_18cb2da3-1420-4260-9314-bbe73e7c96aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ffc482cd-5a18-4a89-925e-0db51a235f73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_d18201b3-9221-4324-94b5-fb35cd30e309" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ffc482cd-5a18-4a89-925e-0db51a235f73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_7ed6dadb-9692-4f86-92de-25bc708f474b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_759fc6df-77d4-4817-a83d-40a2c62e452e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7ed6dadb-9692-4f86-92de-25bc708f474b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_759fc6df-77d4-4817-a83d-40a2c62e452e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_DeferredTaxAssetsLeasingArrangements_cf57380f-241e-418f-ada4-3bed496674c6" xlink:href="rnac-20231231.xsd#rnac_DeferredTaxAssetsLeasingArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7ed6dadb-9692-4f86-92de-25bc708f474b" xlink:to="loc_rnac_DeferredTaxAssetsLeasingArrangements_cf57380f-241e-418f-ada4-3bed496674c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_71e56b34-6d96-4da5-ab4b-ba26ff556ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7ed6dadb-9692-4f86-92de-25bc708f474b" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_71e56b34-6d96-4da5-ab4b-ba26ff556ad1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_bbb0009f-cc3d-46b7-bb77-c6f01cd6093f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7ed6dadb-9692-4f86-92de-25bc708f474b" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_bbb0009f-cc3d-46b7-bb77-c6f01cd6093f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_55c3e796-e8be-48ef-adcb-16a338272f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7ed6dadb-9692-4f86-92de-25bc708f474b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_55c3e796-e8be-48ef-adcb-16a338272f8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_4e9f2407-3f37-4db0-bba1-2296b919de7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7ed6dadb-9692-4f86-92de-25bc708f474b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_4e9f2407-3f37-4db0-bba1-2296b919de7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_f5c87997-2806-4e1c-9068-029780c8fcb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7ed6dadb-9692-4f86-92de-25bc708f474b" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_f5c87997-2806-4e1c-9068-029780c8fcb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_39b91534-2f9c-4116-91cb-fb8b85879ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_7ed6dadb-9692-4f86-92de-25bc708f474b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_39b91534-2f9c-4116-91cb-fb8b85879ec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_DeferredTaxAssetsNetOfDeferredTaxLiabilities_12ba68f3-f7dc-4365-9cb7-fd2f1b986bb8" xlink:href="rnac-20231231.xsd#rnac_DeferredTaxAssetsNetOfDeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_81a64f85-c18b-4d26-b1e2-bfb5313fb729" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rnac_DeferredTaxAssetsNetOfDeferredTaxLiabilities_12ba68f3-f7dc-4365-9cb7-fd2f1b986bb8" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_81a64f85-c18b-4d26-b1e2-bfb5313fb729" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_af4a7131-50e3-4cc8-aa4d-fd7630cc71c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rnac_DeferredTaxAssetsNetOfDeferredTaxLiabilities_12ba68f3-f7dc-4365-9cb7-fd2f1b986bb8" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_af4a7131-50e3-4cc8-aa4d-fd7630cc71c1" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
